[1]Patent:WO2017/32840,2017,A1.Locationinpatent:Page/Pagecolumn234
[1]EuropeanJournalofMedicinalChemistry,2019,vol.162,p.290-320
1021435-01-7
1154741-20-4
1191028-50-8
1233025-78-9
1215767-86-4
122531-09-3
1217462-84-4 | (R)-tert-Butyl 3-ethylpiperazine-1-carboxylate hydrochloride | AA0015NT | MFCD11101230
1217774-23-6 | Trans-4-boc-amino-piperidine-3-carboxylic acid methyl ester | AA0015VL | MFCD09991632
1218790-34-1 | 3-Bromo-5-isopropoxyphenylboronic acid, pinacol ester | AA001661 | MFCD12546586
1219220-82-2 | 1-Boc-azetidine-2-carboxylic acid amide | AA0016C3 | MFCD08274992
1220219-97-5 | 6-Amino-2-methylpyridin-3-ylboronic acid pinacol ester | AA0016K6 | MFCD13182009
1222533-77-8 | 6-Fluoro-3,4-dihydro-1,8-naphthyridin-2(1h)-one | AA0016WY | MFCD16628236
1224944-51-7 | Methyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate | AA00178C | MFCD22551533
137941-45-8 | Arillatose B | AA0017M9 | MFCD18643049
138169-57-0 | 4-Hydroxybenzamide hydrate | AA001819 | MFCD14705667
138302-49-5 | Methyl 2-(oxan-4-ylidene)acetate | AA0018FB | MFCD06410633